Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia

被引:25
作者
Gilabert, J
Estelles, A
Grancha, S
Espana, F
Aznar, J
机构
[1] LA FE UNIV HOSP, RES CTR, VALENCIA, SPAIN
[2] LA FE UNIV HOSP, DEPT CLIN PATHOL, VALENCIA, SPAIN
关键词
fibrinolysis; placenta; plasminogen activator inhibitors; pre-eclampsia; pregnancy; reproduction;
D O I
10.1093/humrep/10.suppl_2.121
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Here we summarize the recent progress in research on the role of the fibrinolytic system in reproduction, with a special emphasis on the role of the plasminogen activator inhibitors in fetal development, Trophoblasts produce fibrinolytic proteins that can promote normal implantation and regulate blood dow to the fetus and placenta throughout pregnancy, Normal pregnancy is associated with a hypofibrinolytic state that is fundamentally caused by an increase in plasminogen activator inhibitors types 1 and 2. In pre-eclampsia, a fibrinolytic failure, resulting from an increase in plasma and placental concentrations of plasminogen activator inhibitor-1, was observed, The localized elevated concentrations of placenta plasminogen activator inhibitor-1 protein and mRNA observed in pre-eclamptic patients would be expected to foster the deposition of fibrin and thus play a role in the complications associated with this disease. The decreased plasminogen activator inhibitor-2 concentrations in placenta and plasma from intrauterine fetal growth retardation pregnancies and the positive correlation between plasma/placenta plasminogen activator inhibitor-2 concentration and birthweight suggest that this inhibitor could be considered an adequate marker of placental function.
引用
收藏
页码:121 / 131
页数:11
相关论文
共 67 条
[31]   HORMONAL-STIMULATION ALTERS THE TYPE OF PLASMINOGEN-ACTIVATOR PRODUCED BY SERTOLI CELLS [J].
HETTLE, JA ;
WALLER, EK ;
FRITZ, IB .
BIOLOGY OF REPRODUCTION, 1986, 34 (05) :895-904
[32]   IMMUNOHISTOCHEMICAL LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND INHIBITOR-2 IN EARLY HUMAN IMPLANTATION SITES [J].
HOFMANN, GE ;
GLATSTEIN, I ;
SCHATZ, F ;
HELLER, D ;
DELIGDISCH, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (02) :671-676
[33]   PLASMINOGEN-ACTIVATOR AND MOUSE SPERMATOZOA - UROKINASE SYNTHESIS IN THE MALE GENITAL-TRACT AND BINDING OF THE ENZYME TO THE SPERM CELL-SURFACE [J].
HUARTE, J ;
BELIN, D ;
BOSCO, D ;
SAPPINO, AP ;
DOMINIQUEVASSALLI, J .
JOURNAL OF CELL BIOLOGY, 1987, 104 (05) :1281-1289
[34]   HEMOSTATIC AND RHEOLOGICAL CHANGES IN NORMAL-PREGNANCY AND PRE-ECLAMPSIA [J].
INGLIS, TCM ;
STUART, J ;
GEORGE, AJ ;
DAVIES, AJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1982, 50 (03) :461-465
[35]  
KEETON M, 1993, AM J PATHOL, V142, P59
[36]  
KLIMAN HJ, 1989, IMPLANTATION, P83
[37]  
KRUITHOF E K O, 1988, Fibrinolysis, V2, P59
[38]  
KRUITHOF EKO, 1987, BLOOD, V69, P460
[39]   PROTEIN-C INHIBITOR IN HUMAN-BODY FLUIDS - SEMINAL PLASMA IS RICH IN INHIBITOR ANTIGEN DERIVING FROM CELLS THROUGHOUT THE MALE REPRODUCTIVE-SYSTEM [J].
LAURELL, M ;
CHRISTENSSON, A ;
ABRAHAMSSON, PA ;
STENFLO, J ;
LILJA, H .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1094-1101
[40]   FIBRINOLYTIC COMPONENTS IN INDIVIDUAL CONSECUTIVE PLASMA SAMPLES DURING NORMAL-PREGNANCY [J].
LINDOFF, C ;
LECANDER, I ;
ASTEDT, B .
FIBRINOLYSIS, 1993, 7 (03) :190-194